Syros Pharmaceuticals, Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Syros Pharmaceuticals, Inc. has filed 682 SEC EDGAR filings since 22 Aug 2012

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 326-350 of 682 matching filings.

Per page

Current page

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 18 Feb 2021
Reporting date: 16 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

SC 13G/A

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

SCHEDULE 13G (AMENDMENT #1)

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

SC 13G/A

Filing date: 11 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 10 Feb 2021
Reporting date: 08 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 10 Feb 2021
Reporting date: 16 Nov 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

SC 13G/A filing

Filing date: 08 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

AMENDMENT NO. 2

Filing date: 05 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-37813

CT ORDER filing

Filing date: 03 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS -- SCH 13G/A (#4E)

Filing date: 02 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89552

SC 13G/A filing

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-251941

424B3

Filing date: 27 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37813

8-K

Filing date: 20 Jan 2021
Reporting date: 19 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-239141

424B5

Filing date: 20 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-251941

EFFECT filing

Filing date: 19 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-239141

424B5

Filing date: 19 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37813

8-K

Filing date: 19 Jan 2021
Reporting date: 19 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 14 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 13 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37813

8-K

Filing date: 11 Jan 2021
Reporting date: 08 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-3 File 333-251941

S-3

Filing date: 07 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing